Ferroptosis Inducer Improves the Efficacy of Oncolytic Virus-Mediated Cancer Immunotherapy
Ferroptosis is a type of programmed cell death dependent on iron and characterized by the accumulation of lipid peroxides. In this study, we explore the combination of a ferroptosis activator with an oncolytic vaccinia virus in tumor models. Erastin induced cell death in hepatoma, colon, and ovarian...
Main Authors: | Weilin Liu, Hongqi Chen, Zhi Zhu, Zuqiang Liu, Congrong Ma, Yong J. Lee, David L. Bartlett, Zong-Sheng Guo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-06-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/10/6/1425 |
Similar Items
-
Oncolytic viruses as anticancer vaccines
by: Norman eWoller, et al.
Published: (2014-07-01) -
The Role of Neutrophils in Oncolytic Orf Virus-Mediated Cancer Immunotherapy
by: Jessica A. Minott, et al.
Published: (2022-09-01) -
Curcumin reverses erastin-induced chondrocyte ferroptosis by upregulating Nrf2
by: Yizhao Zhou, et al.
Published: (2023-10-01) -
Capitalizing on Cancer Specific Replication: Oncolytic Viruses as a Versatile Platform for the Enhancement of Cancer Immunotherapy Strategies
by: Donald Bastin, et al.
Published: (2016-08-01) -
Oncolytic Viruses: Newest Frontier for Cancer Immunotherapy
by: Masmudur M. Rahman, et al.
Published: (2021-10-01)